GENE ONLINE|News &
Opinion
Blog

Go Prime
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
The FDA and Biogen Taking Heat for Aduhelm’s Approval Process
2022-12-30
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
Will Biden’s Biomanufacturing Initiative Kill Korean Partnership?
2022-10-12
Mounting Criticisms of FDA’s Accelerated Approval Pathway Could Prompt Changes to the System
2022-08-25
NIH Provides $23 Million to Fund Telehealth Cancer Care Research
2022-08-22
2026: The Promise of Synthetic Biology
2022-08-11
How Governments Around the World Should Respond to the Mounting Costs of Gene and Cell Therapy?
2022-07-08
America’s Ongoing Battle For Lower Insulin Prices
2022-06-23
Convergence, Communication and Commercialization, The Cornerstones In Emerging Regulatory Trends
2022-05-24
The FDA Issued its First Formal Warning to Companies Selling Delta-8 THC Products
2022-05-05
These Two Companies are Helping Push Denmark to the Forefront of Biotech
2022-04-21
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
Compensating for OxyContin: The Harm from Pharma
2022-04-12
Insider: Groundbreaking Malaria Vaccine Reinvigorates the Fight against Disease
2022-03-30
1 2 3 10
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!